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European life will never be the same again.1 The coronavirus pandemic has, and will, 
dramatically change how medicine is practised now and in the future. It also brings home, in 
case we did not realise it, how we are all interconnected and interdependent. What can we 
do to help in these uncertain times? 
 
The SARS-CoV-2 virus is highly contagious - it does not respect borders, countries, societies, 
communities or families. Even with most of the world in lockdown, clinicians are battling 
with support measures for those with severe COVID-19. Healthcare resources are being 
diverted pragmatically to source masks, virology services, personal protective equipment 
and ventilators as well as building field hospitals and, sadly, morgues. Emergency care is 
taking over the time, resources and premises normally used for routine care. The loss of 
sexual and reproductive health services, deemed by some governments as non-essential, 
poses significant challenges for all of us.  
 
It is likely that the amount of time dedicated to sexual intercourse (at least with regular 
partners) during social distancing, isolation and working from home has increased. 
Lockdowns and travel restrictions are hampering access to contraceptive supplies and 
services across the world.2 These factors could lead to millions of additional unintended 
pregnancies, millions of unsafe abortions and thousands of resultant deaths. 
 
History has taught us that sexual and reproductive health and rights are often casualties of 
conflicts and emergencies3 - this virus is no different as it wreaks havoc globally. The 
incidence of domestic violence,4 rape (and likely STIs too) increases while access to services 
become almost non-existent. Rape and domestic violence increase the need for emergency 
contraception, abortion and contraception in the first instance. As always, marginalised 
individuals and communities suffer proportionately more. 
 
The reported demand for condoms has risen sharply5 as accessibility to contraception and 
abortion is significantly reduced. Yet condom manufacture is not considered an essential 
service and some condom factories, importantly in Asia, are in lockdown. 
 
We need to be innovative in our service provision; in this we need national authorities to 
react swiftly to facilitate this. Health Ministries need to be ready to make emergency 
modifications to relevant regulations, for example those that insist upon multiple doctors’ 
signatures, face-to-face consultations and waiting periods. Drug regulators need to urgently 
vary licences to make a range of prescription-only contraceptive products available under 
the supervision of a pharmacist. 
 
New, simplified guidelines and protocols are being written speedily.6 7 Telemedicine with 
video consultations and remote prescribing are now the new reality. This cannot be done 
without the support of pharmacies - who are themselves subject to increased workload and 
constrained by breakdowns in supply chains, particularly from China and India.8 Infection 
testing can be done in some places using postal services e.g. https://sh24.org.uk/sexual-
health/stis . 
 
The European Society of Contraception and Reproductive Health, in an endeavour to 
support our colleagues and provide the best service possible in the circumstances, proposes 
the following measures: 
 
1. Adoption or extension of new models of care such as task-sharing.9 
 
2. Remote consultations and prescribing for complex contraception needs and, 
particularly, for medical abortion at home (telemedicine).10 
 
3. The extended use of long-acting reversible contraception (etonogestrel implants and 
52-mg levonorgestrel-releasing intrauterine contraceptives) up to one year beyond 
their lifespan.11   
 
4. The use of oral progestogen-only contraception as a supplement to, or a substitute 
for, existing contraceptive methods, where appropriate. 
 
5. Continued use of combined oral contraception over time for low-risk users, without 
the need for routine checks.  
 
These are simple measures that, with the support of pharmacies, will support a continued  
service and, although not ideal, will hopefully ameliorate the situation and relieve the plight 
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